Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Asset Writedowns and Impairment (2018 - 2020)

Historic Asset Writedowns and Impairment for Qiagen (QGEN) over the last 3 years, with Q4 2020 value amounting to $398000.0.

  • Qiagen's Asset Writedowns and Impairment fell 6686.09% to $398000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $140.1 million, marking a year-over-year increase of 87.83%. This contributed to the annual value of $22.4 million for FY2025, which is 8896.8% down from last year.
  • Per Qiagen's latest filing, its Asset Writedowns and Impairment stood at $398000.0 for Q4 2020, which was down 6686.09% from $958000.0 recorded in Q1 2020.
  • Qiagen's 5-year Asset Writedowns and Impairment high stood at $137.6 million for Q3 2019, and its period low was $22000.0 during Q4 2018.
  • Its 3-year average for Asset Writedowns and Impairment is $23.4 million, with a median of $678000.0 in 2020.
  • As far as peak fluctuations go, Qiagen's Asset Writedowns and Impairment skyrocketed by 535909.09% in 2019, and later tumbled by 6686.09% in 2020.
  • Qiagen's Asset Writedowns and Impairment (Quarter) stood at $22000.0 in 2018, then surged by 5359.09% to $1.2 million in 2019, then plummeted by 66.86% to $398000.0 in 2020.
  • Its Asset Writedowns and Impairment was $398000.0 in Q4 2020, compared to $958000.0 in Q1 2020 and $1.2 million in Q4 2019.